Abstract
Uroplakins (UPs) play an essential role in maintaining an effective urothelial permeability barrier at the level of superficial urothelial cell (UC) layer. Although the organization of UPs in the apical plasma membrane (PM) of UCs is well known, their transport in UCs is only partially understood. Here, we dissected trafficking of UPs and its differentiation-dependent impact on Golgi apparatus (GA) architecture. We demonstrated that individual subunits UPIb and UPIIIa are capable of trafficking from the endoplasmic reticulum to the GA in UCs. Moreover, UPIb, UPIIIa or UPIb/UPIIIa expressing UCs revealed fragmentation and peripheral redistribution of Golgi-units. Notably, expression of UPIb or UPIb/UPIIIa triggered similar GA fragmentation in MDCK and HeLa cells that do not express UPs endogenously. The colocalization analysis of UPIb/UPIIIa-EGFP and COPI, COPII or clathrin suggested that UPs follow constitutively the post-Golgi route to the apical PM. Depolymerisation of microtubules leads to complete blockade of the UPIb/UPIIIa-EGFP post-Golgi transport, while disassembly of actin filaments shows significantly reduced delivery of UPIb/UPIIIa-EGFP to the PM. Our findings show the significant effect of the UPs expression on the GA fragmentation, which enables secretory Golgi-outpost to be distributed as close as possible to the sites of cargo delivery at the PM.
Introduction
Plasma membrane proteins must be correctly synthesized, processed and transported to the plasma membrane (PM) in order to perform their specialized function. Four major transmembrane proteins, the uroplakins (UPs), i.e., UPIa (27 kDa), UPIb (28 kDa), UPII (15 kDa) and UPIIIa (47 kDa)1–5 are expressed in a differentiation-dependent manner2,6 and are highly organized in so called urothelial plaques in the apical PM of highly differentiated superficial urothelial cells (UCs)7,8. When they are correctly assembled in the apical PM they provide the structural basis for the blood-urine barrier in the urinary bladder. Recently, it was shown that loss of UPIb results in urothelial plaque disruption in the bladder9. Moreover, the fact that no truncation or frame shift mutations of uroplakins have been found in any of primary vesicoureteral reflux (VUR) patients and that some breeding pairs of UPIII knockout mice yield litters that show not only small urothelial plaques, urothelial leakage and VUR, but also severe hydronephrosis and neonatal death, raises the possibility that major uroplakin mutations could be embryonically or postnatally lethal in humans10–12. Although the organization of UPs in the apical PM of UCs is well known, the biosynthetic pathway of UPs and their transport in UCs is still not completely understood.
Various studies examining UP transport predict a model of UP synthesis and their assembly into urothelial plaques. Based on this model UPs are synthesized in the ER where they must form two types of heterodimers (UPIa/UPII and UPIb/UPIIIa) before they can exit the ER13. UP-heterodimers are probably transported from the ER to the Golgi apparatus (GA), since UPIb isolated from mouse and human urothelial plaques, and UPIIIa isolated from mouse, cattle and human urothelial plaques contain complex glycans, which are added to the proteins in the GA14–16. The involvement of the GA in the modification of UPs is supported also by the observation that the prosequence of UPII can be cleaved by the GA-protease furin17. Sugar modifications and conformational changes of UPs probably induce the formation of a heterotetramer (UPIa/UPII-UPIb/UPIIIa). Six heterotetramers assemble into 16-nm uroplakin particle7,18. In post-Golgi vesicular compartments these 16-nm UP particles gradually arrange into semi-crystalline urothelial plaques19,20. Indeed first descriptions of the urothelial plaque structure in trans GA network are dating back to the 70s21,22, when first indication of GA contribution in UP biosynthetic pathway was shown in rat urothelium23 and urothelial plaque structures were shown in the GA by freeze-fracturing21,22. Freeze-fracture images disclosed post-Golgi vesicular compartments, namely UP-positive discoidal or fusiform-shaped vesicles (DFVs) in close association with the GA and the apical PM. Since the size of urothelial plaques on the membrane of DFVs resemble those found in close proximity to larger ones in the apical PM, it is believed that these associations are ideally configured to function in the intracellular synthesis and transport as well as the cytoplasmic-plasmalemmal transfer and the progressive incorporation of UPs into urothelial plaques in the apical PM24. Additional insights into the formation of urothelial plaques, i.e. their gradual aggregation or segregation in the apical PM of superficial UCs were shown from a combination of various microscopic techniques8. All these results therefore predicted the classical ER-GA pathway of UP biosynthesis. However, UPs have never been demonstrated in the GA, which opens the possibility that UPs could also bypass the GA. Supporting this hypothesis is the finding that UPIa and occasionally UPIb isolated from the plaques contain high-mannose residues added in the ER14, while in theory these residues should be removed from the proteins only in the GA.
We have shown previously that the GA undergoes major structural rearrangement during UC differentiation in vivo and in vitro 25,26. In this process the GA changes from a small ribbon like form which is positioned close to the nucleus into a large fragmented form that is spread throughout the cytoplasm of superficial UCs. Because increased synthesis of UPs coincides with the fragmentation of the GA, it is proposed that fragmentation of the GA and its redistribution to the cell periphery represent one of the key events that promote the uniform delivery of UPs to the apical PM26. Although our data suggested that the GA has a central role in the biosynthetic pathway of UP transport, neither the mechanisms nor the reason(s) of GA fragmentation are known.
In the transport of UPs from the GA to the apical PM the cytoskeleton plays an important, but not fully understood role. For example, it was shown that cytokeratins form a specific network that may regulate the transport of UPs-delivering vesicles to the apical PM27,28. Interestingly, actin filaments (AFs) are greatly retracted from the subapical cytoplasm of terminally differentiated superficial UCs29 and also microtubules (MTs) are rearranged during the differentiation of UCs26,30.
In this study, we generated specific UP cDNA constructs to follow the biosynthetic pathway of UPIb and UPIIIa, and examined the dynamics of UPIb/UPIIIa transport in living UCs. Using cell transfection, we also studied biosynthesis and transport of UPIb/UPIIIa in MDCK and HeLa cells, which do not synthesize UPs endogenously. With the aid of time-lapse microscopy, immunohistochemistry and electron microscopy (EM), we showed that transport of UPIb or UPIb/UPIIIa through the GA cause fragmentation and redistribution of the GA both in UCs and in cells that do not express UPs endogenously. Furthermore, the involvement of MTs and AFs in UP transport to the PM was revealed. Our findings elucidate how UCs adopted the biosynthetic pathway and transport mechanisms to ensure the assembly and delivery of their specific cargo – namely UPs - to the apical PM.
Results
Normal porcine UC cultures synthesize UPs and form urothelial plaques
To achieve highly differentiated UCs, we grew normal porcine UCs first in medium with low Ca2+ concentration and added serum for 7 days, which stimulates proliferation and leads to confluence, and then in medium with high Ca2+ concentration and without serum for 60 days that leads to stratification and differentiation31,32. First, RT-qPCR analysis of individual subunits UPIb and UPIIIa confirmed their expression in highly differentiated UCs in vitro (see Supplementary Fig. S1). Next, we therefore analysed UP expression at the protein level and UP cellular localization. Immunofluorescence labeling with a rabbit polyclonal antibody against all four UPs (anti-UPs)1 showed UP-positive apical PM of superficial UCs in an established three-to-five-layered urothelial model (Fig. 1A). Scanning EM analysis of the cell surface topography revealed an apical PM of superficial UCs mainly shaped in rounded ridges and rarely in microvilli (Fig. 1B), which is all in line with our previously published results32,33. In addition, the immunofluorescence labeling of cryo semi-thin sections with antibodies against UPIa, UPIb, UPII and UPIIIa showed positive signals of all four UPs in superficial UCs (Fig. 1C). All four UPs in the apical PM of UCs were additionally confirmed by the freeze-fracture replica immunolabeling (FRIL) technique (Fig. 1D). FRIL showed that anti-UPs antibodies recognized intramembrane particles that most likely represent 16-nm UP particles, which were organized into urothelial plaques (Fig. 1D). Between plaques there were areas devoid of UP particles, probably representing so called hinge regions. These results demonstrated that endogenously expressed UPs are not only targeted to the apical PM of normal porcine UCs in vitro, but also form urothelial plaques in these cells, which is novel.
Together our data show that normal porcine UCs in culture reach a high differentiation stage that is comparable to the differentiation stage of superficial UCs of normal urothelium in vivo in various species34–36 and therefore can be used as a suitable model for studies of UP transport.
Individual EGFP-tagged UP subunits exhibit different ability to reach the apical PM of polarized UCs or MDCK cells
First we tested whether EGFP–tagged UPIb and UPIIIa arrive at the apical PM in the same way as endogenous UPIb and UPIIIa in UCs. After transfection of UCs with UPIb-EGFP and UPIIIa-EGFP, the signal of UPIb-EGFP and UPIIIa-EGFP was located at the apical PM (Fig. 2A,B). These observations confirmed that the assembly, sorting and targeting of UPs to the apical PM of polarized UCs are not affected by the attached EGFP to the cytoplasmic tail of UPIb (i.e. UPIb-EGFP) and UPIIIa (i.e. UPIIIa-EGFP). Next, we wanted to confirm that transport of EGFP-tagged UPIb and UPIIIa to the apical PM can also be studied in other cell lines, like polarized epithelial MDCK cells. We transfected MDCK cells with UPIb-EGFP, UPIIIa-EGFP and UPIb/UPIIIa-EGFP (see Supplementary Tables S1 and S2). Confocal images revealed UPIb-EGFP signal in the apical PM above the immunolabelled tight junctional protein occludin (Fig. 2C). In contrast, when UPIIIa-EGFP was expressed alone, its signal overlapped with the signal of ER Tracker (see Supplementary Fig. S2). UPIIIa-EGFP signal was observed in vesicles and at the apical PM when co-expressed with its partner UPIb (Fig. 2D). To further confirm correct targeting of UPIb-EGFP and UPIb/UPIIIa-EGFP to the apical PM, we performed immunoelectron microscopy. Immunolabeling of EGFP confirmed the presence of UPIb-EGFP and UPIb/UPIIIa-EGFP in the apical PM of polarized MDCK cells (Fig. 2E,F).
Together, our results indicated that EGFP-tag does not interfere with the transport of UPIb and UPIIIa to the apical PM of polarized UCs and MDCK cells.
Transport of UPs through the GA causes its fragmentation in different cell types
We have shown previously that the GA undergoes fragmentation during differentiation of UCs26, which probably facilitates the delivery of UPs over the entire apical PM of differentiating UCs. Here we further investigated the possible mechanisms and the reasons of GA fragmentation. Our aims were to find out (1) whether UPIb and UPIIIa passes the GA, (2) if GA fragmentation is intrinsic to UCs, (3) whether UP synthesis and transport are involved in fragmentation and redistribution of the GA, and (4) whether UPs cause fragmentation of the GA through induction of apoptosis.
First, fluorescence labelling with ER and GA markers showed that UPIb-EGFP and UPIb/UPIIIa-EGFP colocalize with ER (Supplementary Fig. S2) and markers of GA (GM130, giantin and golgin 97) in UCs (Fig. 3) and also in MDCK cells (Fig. 4A,B). The presence of UPIb-EGFP and UPIb/UPIIIa-EGFP in the GA was further confirmed by immunoelectron microscopy (Fig. 4C,D). Moreover, in UCs also UPIIIa-EGFP colocalized with ER and GA (data not shown), probably due to its endogenously expressed partner UPIb. These results prove that UPIb and UPIb/UPIIIa are transported via the classical ER-GA pathway as was proposed in previous studies17,37.
Second, we analyzed the GA architecture in UP-expressing and control (non-transfected) MDCK and HeLa cells. We found that fragmentation of the GA is not intrinsic only to UCs, but also to cells transfected with UP cDNA constructs (see Supplementary Tables S1 and S2). UPIb, UPIb-EGFP, UPIb/UPIIIa, or UPIb/UPIIIa-EGFP transfected MDCK and HeLa cells exhibited increased fragmentation of the GA in comparison to the control cells and in comparison to the cells expressing other GFP-tagged apical protein, GPI-GFP (Fig. 5 and Supplementary Figs S3 and S4). The analysis of untagged and EGFP-tagged UPs showed that EGFP tags do not increase the number of GA fragments (see Supplementary Fig. S4), while the expression of EGFP alone did not change the GA structure (data not shown). At the beginning of synthesis, when UPIb-, UPIIIa-, and UPIb/UPIIIa-EGFP still remain in the ER, the GA does not exhibit significant fragmentation (see Supplementary Table S3).
Third, the first changes in GA structure were only observed when UPs were detected within the GA, post-Golgi carriers/vesicles or at the PM (see Supplementary Table S3). Results of quantitative analyses of GA fragmentation are shown in Supplementary Fig. S4. The average number of GA fragments in UPIb-EGFP transfected MDCK cells was 60 ± 2.9 (s.e.m.; n = 10) and in HeLa cells it was 83.1 ± 6.9 (s.e.m.; n = 10). Similar, the average number of GA fragments in UPIb/UPIIIa transfected MDCK cells was 32.6 ± 4.4 (s.e.m.; n = 10) and HeLa cells was 45.8 ± 5.9 (s.e.m.; n = 10). This was statistically higher than the number of GA fragments in control non-transfected cells (7 ± 1 fragments (s.e.m.; n = 10) in MDCK; and 2.9 ± 0.5 (s.e.m.; n = 10) in HeLa cells) (see Supplementary Fig. S4A). To measure the extent of the GA fragmentation, we calculated the Euclidean distance, which determines the distance between two points. We observed increased Euclidean distance between GA fragments in UP-expressing cells in comparison with the control MDCK and HeLa cells (see Supplementary Fig. S4B). These results are in accordance with the increased number of GA fragments and Euclidean distance in differentiating UP-expressing UCs26. Moreover, a cluster analysis revealed that transfection with UP cDNA constructs did not affect significantly the number of GA fragments per cluster in MDCK and HeLa cells (see Supplementary Fig. S4C). All together, we demonstrated that transport of UPs across the GA triggers fragmentation of the Golgi ribbon in UCs as well as in UP-expressing MDCK and HeLa cells.
Fourth, since the GA undergoes irreversible fragmentation during apoptosis, in part as a result of caspase-mediated cleavage of several Golgi-associated proteins38, we next analyzed whether the synthesis of UPIb-EGFP and UPIb/UPIIIa-EGFP activate caspase 3, which plays a central role in the execution-phase of cell apoptosis. Confocal images did not reveal caspase 3 activation in UPIb-EGFP or UPIb/UPIIIa-EGFP expressing MDCK and HeLa cells (see Supplementary Fig. S5). The image analysis revealed that there was no active caspase 3 positive UP expressing UCs (n = 3) and MDCK cells (n = 4), and only 3 (6.7%) of UP expressing HeLa cells (n = 45) were also active caspase 3 positive. Altogether, only 5.8% of all analyzed UP expressing cells were active caspase 3 positive. Therefore it turns out that UPs cause fragmentation of the GA through their trafficking along the secretory pathway and not through induction of apoptosis.
UPIb/UPIIIa-EGFP exit from the GA in COPI-, COPII- and clathrin-negative transport carriers
To check whether the peripheral UPIb/UPIIIa-EGFP vesicles exiting from the GA contain any of coated proteins, the immunofluorescence labeling of COPI, COPII and clathrin was performed on MDCK cells after synchronization of the protein release with brefeldin A and temperature block, and further prevention of the vesicle fusion with the PM by tannic acid treatment. The colocalization between UPIb/UPIIIa-EGFP and COPI, COPII or clathrin was analyzed in z-stacks acquired by the confocal microscope. Representative images show rare overlap of UPIb/UPIIIa-EGFP signals and signals of COPI (Fig. 6A), COPII (Fig. 6B) and clathrin (Fig. 6C). Furthermore, quantitative analyses confirmed only a moderate degree of co-localization (Fig. 6D).
To further check the presence of coated proteins at the surface of UP-positive vesicles in UCs, which express UPs endogenously, the immunofluorescence labeling on cryo semi-thin sections was performed. We found no overlapping signals of UPs with COPI, or clathrin in UCs. However, as expected, there were some overlapping signals between giantin and COPI as well as between giantin and clathrin (Supplementary Fig. S6).
These results correlated well with our previous findings that constitutive post-Golgi carriers do not contain any of COPI, COPII and clathrin positive vesicles39. Our observations may therefore suggest that UPs follow the constitutive post-Golgi route to the apical PM.
Microtubules and actin filaments are required for UP trafficking to the plasma membrane
It was shown previously that rearrangement of MTs and AFs occurs during differentiation of UC26,29,30. Here we present evidence for the association of both MTs and AFs with UP-positive vesicles, which we assume to resemble discoidal or fusiform-shaped vesicles (DFVs) in UCs before reaching terminally differentiated stage. Immunofluorescence labelling showed a close association of UPIb/UPIIIa-EGFP containing vesicles with both α-tubulin and F-actin in MDCK cells (Fig. 7). UPIb/UPIIIa-EGFP vesicles overlapped with α-tubulin-positive microtubules throughout the cytoplasm (Fig. 7A) and with F-actin filaments only in the peripheral area of the cytoplasm underneath the PM (Fig. 7B).
We used time lapse confocal microscopy to analyze the dynamics of the transport from the GA to the PM by tracking individual UP positive vesicles (Fig. 8 and Supplementary Video S1). UPIb/UPIIIa-EGFP positive vesicles were not directly transported to the PM. Instead they moved in saltatory manner (transiently stopped or changed the direction). To evaluate the average velocity of UPIb/UPIIIa-EGFP positive vesicles we subtracted these halts and direction reversals. The average velocity of UPIb/UPIIIa-EGFP positive vesicles in UCs was 0.31 ± 0.01 µm/s (s.e.m.; n = 69) and in MDCK cells 0.35 ± 0.01 µm/s (s.e.m.; n = 98). The maximal velocity of UPIb/UPIIIa-EGFP positive vesicles in UCs was 1.71 µm/s and in MDCK cells 2.62 µm/s. That is consistent with the speed of the movement along microtubules40.
Next, we used time-lapse confocal microscopy to monitor the dynamics of UPIb/UPIIIa-EGFP transport in MDCK cells where the MTs were depolymerized with nocodazole (NOC). The movement of UPIb/UPIIIa-EGFP positive vesicles almost completely stopped indicating again the involvement of MTs in UPs transport (Fig. 8B and Supplementary Video S2).
To test the role of AFs in the transport of UPIb/UPIIIa-EGFP positive vesicles, we analyzed the dynamics of UPIb/UPIIIa-EGFP transport in MDCK cells incubated with cytochalasin D (CytD) to prevent polymerization of actin monomers. CytD-treated cells exhibited a significant decrease in the motility of UPIb/UPIIIa-EGFP positive vesicles and in their fusion with the PM (Fig. 8C and Supplementary Video S3).
In summary, the fluorescence immunolabelling of α-tubulin or F-actin with UPIb/UPIIIa-EGFP in MDCK cells, together with studies on the transport dynamics of UPIb/UPIIIa-EGFP positive vesicles in non-treated and NOC and CytD treated cells, provided the first evidence of the involvement of MTs and AFs in the transport of UPs to the PM.
Discussion
Differentiation of the UCs includes many cellular mechanisms involved in the development of a specialized apical PM of superficial UCs that contains transmembrane proteins UPs. One of these cellular mechanisms requires the fragmentation of the GA25,26. Studies have suggested that the GA plays a central role in the complex formation of UPs, which are subsequently delivered to the apical PM during the differentiation of UCs19,26 and contribute to the formation of the tightest permeability barrier in the body41,42. However, the presence of UPs in the GA was never demonstrated in situ. It was shown that the GA undergoes structural rearrangement, which includes fragmentation of the GA and it’s spreading throughout the cytoplasm of the differentiating UCs25,26. The purpose of our study was therefore to elucidate the biosynthetic pathway of UPIb and UPIIIa from the ER to the PM with special emphasis on the question whether the presence and transport of UPs are involved in GA fragmentation.
In this study, we showed that UCs in the established cultures endogenously express all four UPs, Additionally, employing the FRIL technique, we confirmed the presence of UP particles in the apical PM of UCs. UP particles have been so far found only in highly differentiated superficial UCs (i.e. umbrella cells) of normal urothelium in vivo and in primary cultures of normal mouse UCs24.
With the transfection of established UC cultures with UPIb-EGFP or UPIb/UPIIIa-EGFP we ensured that EGFP-tagged UPs maintained ability to assemble with their partners and that they are delivered to the apical PM of polarized UCs. Our results showed that UPIIIa-EGFP can exit the ER in UCs, which endogenously express its partner UPIb, however it cannot exit the ER alone in 90% of the transfected MDCK cells (see Supplementary Table S3). Similar results were obtained also with 293 T cell13. We showed that UPIIIa-EGFP can be found in apical PM of MDCK cells when cotransfected with its partner UPIb. Therefore we conclude that the assembly of UPIIIa-EGFP with UPIb is necessary to be able to exit the ER.
UPIb-EGFP and UPIb/UPIIIa-EGFP have been found in the apical PM of polarized MDCK cells demonstrating that UPIb and UPIb/UPIIIa are directed to the apical PM also in cells which do not usually express UPs. Delivery of UPIb and UPIIIa to the apical PM suggests that at least UPIb contains the sorting signal that direct UPIb and UPIb/UPIIIa to the apical PM. Apical sorting signals can be localized to the cytoplasmic, luminal, and transmembrane domains of the proteins43. GPI-anchors, and N- and O-glycans attached to the membrane proteins can act as an apical sorting signal44. However, the sorting signals and sorting mechanisms of UPs remain to be discovered.
Newly synthesized proteins that leave the ER usually pass through the GA before being sorted for transport to their final destination. The glycosylation of UPIb, UPII, and UPIIIa as well as cleavage of UPII by furin suggest UP transport through the GA14,17. However, UPs have never been detected in the GA cisternae in situ. Possibly this happened due to the properties of utilized antibodies, which recognize only mature UPs. Another explanation for this lack of UPs in the GA is that UPs bypass GA, as it is known for protein-tyrosine phosphatase CD45, peripherin/rds and myeloproliferative leukemia virus oncogene45–47. Nevertheless, our results showed that UPs can be revealed both in ER and in the GA. This argues that UPs take conventional ER-to-Golgi-to-PM trafficking pathway.
The GA undergoes irreversible fragmentation during apoptosis, which is due in part to caspase-mediated cleavage of Golgi-associated proteins48; however this was not the case in UPs-expressing cells used in our study. Our results show that UPIb and UPIb/UPIIIa expression is associated with the fragmentation of the GA in UCs which express UPs endogenously, and in MDCK and HeLa cells, which do not express UPs endogenously. The results of the quantification analysis of the number of GA fragments in MDCK and in HeLa cells during the UP transport in this study coincide with the number of GA fragments in highly differentiated UCs26. These results additionally confirm a relationship between increased UP expression and fragmentation of GA.
We believe that the fragmentation of the GA during the differentiation process of the cells is not an uncommon event amongst different cell types. Comparable fragmentation and redistribution of GA has been observed also in MDCK cells that secrete human growth hormone49 and in differentiated muscle cells50. Probably similar structural changes of the GA occur in other cell types as an adaptation to elevate synthesis of different proteins51 and secretory demand of the cell that requires secretory Golgi outpost to be moved as close as possible to the sites of cargo delivery to the PM. Furthermore, synchronized reorientation of the GA along with the microtubule-organizing center is thought to facilitate polarized secretion, thereby providing membrane and secreted products directly to the nearest PM site such as the leading edge in migrating cells52 or in our case flattened apical surface of UCs. Our results together suggest that fragmentation and spreading of the GA in UCs is related to the (1) level of the UP synthesis, (2) secretory demand of the UCs and (3) shape and size of the UCs.
Analysis of Golgi-derived structures that carry UPs to the PM revealed neither COPI nor COPII nor clathrin at their surface. Presumably, COPI-dependent vesicles are too small for the transport of large cargo aggregates including proteinaceous membrane thickenings in UCs (reviewed in51). This suggests that UP-containing structures are likely to use post-Golgi trafficking mechanisms, which are utilized by number of constitutively secreted cargo proteins39,53–55. One of the common features in these mechanisms is movement of post-Golgi carriers along MTs56,57 and involvement of AFs in post-Golgi secretion58.
We demonstrated the co-localization of MTs and AFs with UPIb/UPIIIa-EGFP positive vesicles and determined the velocity of them. The maximum velocity of UPIb/UPIIIa-EGFP (2.62 µm/s) implies that the transport depends on MTs, since dyneins and kinesins enable the velocity of 0.5–4 µm/s59,60. However, myosins on AFs only enable a velocity of under 0.7 µm/s61 and the average velocity of UPIb/UPIIIa-EGFP (0.35 µm/s) suggests that the transport of UPIb/UPIIIa-EGFP depends also on AFs. As expected from the immunolabeling results, analysis of UPIb/UPIIIa-EGFP transport in cells with depolymerized MTs and AFs confirmed the involvement of MTs and AFs in UP transport. In the presence of the MT-disrupting agent NOC, UPIb/UPIIIa-EGFP positive vesicle movement almost completely stopped, failed to acquire directed motility, and remained stationary in GA. In contrast, inhibition of AF formation with CytD resulted in a slow motility with inability in the targeting of UPIb/UPIIIa-EGFP positive vesicles to the PM. Our results suggest that UPIb/UPIIIa-EGFP positive vesicles from GA to PM first move along MTs, which enable transport of higher velocity. However, closer to the PM UPIb/UPIIIa-EGFP positive vesicles passes to AFs, which enable lower velocity of transport, and therefore prepare UPIb/UPIIIa-EGFP positive vesicles for targeting to the PM.
We propose that upper described mechanism of UP-trafficking prevails in still differentiating UCs. When UCs become terminally differentiated with the bulk of UPs already at the apical PM, the MTs and AFs are reorganized26. MT organization in the basal, central and subapical cytoplasm of highly differentiated UCs is diminished and AFs are mainly depleted from the subapical cytoplasm30,62. In contrary, intermediate filaments are accumulated in the apical cytoplasm, which probably hinder MT-dependent centralization of GA and maintain the peripheral fragmentation of GA in differentiated UCs.
In summary, in this study new perspectives have emerged regarding the explanation of the UPs biosynthetic pathway and differentiation-dependent GA fragmentation. We showed that normal porcine UCs in culture can express all four UPs and are therefore a useful model for studies of dynamic processes that are comparable to normal UC of urothelium in vivo. Our results show that EGFP tagged UPs preserve their ability to form heterodimers and are correctly delivered to the PM. The passage of UPs (Ib, IIIa) through the GA induces its fragmentation not only in UCs, but also in cells that do not express UPs endogenously. MTs support the traffic of UP-positive vesicles from the GA while AFs contribute to their delivery to the PM. Although GA fragmentation was so far very well recognized in conjunction with mitosis63 and apoptosis38, we propose that GA fragmentation can also be needed for delivery of certain specific cargoes to PM. It will be important to understand how the trafficking machinery of the cells drives GA fragmentation in response to expression of such cargo proteins and whether such adaptation of the secretory system requires changes in the transcriptional program of the cells during differentiation.
Methods
Cell cultures
Cell cultures of normal UCs were established from normal porcine urinary bladders26,32. The experiments were approved by the Veterinary Administration of the Slovenian Ministry of Agriculture and Forestry in compliance with the Animal Health Protection Act and the Instructions for Granting Permits for Animal Experimentation for Scientific Purposes.
Urinary bladders were cut into 5 cm long and 2 cm wide strips and UCs were gently scraped from the urothelium with a scalpel and collected in UroM medium as described32. After collection of UC, the cells were centrifuged at 200 g for 5 min, washed in UroM medium and filtered through a 40 µm Cell strainer (BD FalconTM, BD Biosciences, New Jersey, USA) to obtain a single-cell suspension. Primary and subsequent subcultures were plated with a seeding density of 2 × 105 cells/cm2. They were grown in UroM with 0.9 mM calcium and 2.5% FBS (Gibco) until confluence and then transferred to UroM with 2.7 mM calcium and without FBS64,65. For the experiments in this study, UCs from the IV to X passages were used. When non-polarized UCs were acquired, the experiments were performed 24 h after the plating and when polarized UCs cells were acquired, the experiments were performed 5 days after the plating. To obtain highly differentiated UCs, the cells were cultured for 2 months.
MDCK cells were maintained in DMEM (Clonagen Inc, Gentaur, Belgium) supplemented with 10% FBS (EuroClone®, Pavia, Italy), 1 mM L-glutamine (Sigma‒Aldrich), 5% sodium pyruvate (Gibco), 5% non-essential amino acid (Gibco), 7.5% sodium hydrogen carbonate (Sigma‒Aldrich), and 1% Penicillin-Streptomycin (Sigma‒Aldrich). When non-polarized MDCK cells were acquired, the experiments were performed 24 h after the plating and when polarized MDCK cells were acquired, the experiments were performed 5 days after the plating.
HeLa cells were maintained in DMEM (Gibco) supplemented with 10% FBS (EuroClone®), 1 mM L-glutamine (Sigma‒Aldrich), and 1% Penicillin-Streptomycin (Sigma‒Aldrich). All experiments were performed 24 h after the plating.
All three cell types were cultured until use at 37 °C in a 95% humidified atmosphere with 5% CO2.
RNA preparation and RT-qPCR
To determine if 2 months cultured UCs synthesize UPIb and UPIIIa the RT-qPCR was performed. UCs were homogenized with TRIzol reagent and lysed directly in the culture dish. Total RNAs from these cells were purified according to the manufacturer’s instructions. Total RNA (1 μg) was reverse-transcribed by QuantiTect Reverse Transcription kit (Qiagen) according to the manufacturer’s instructions.
RT-qPCR experiments were performed using Light Cycler 480 Syber Green MasterMix (Roche) for cDNA amplification and LightCycler 480 II (Roche) for signal detection. qPCR results were analyzed using the comparative Ct method normalized against housekeeping gene GAPDH. Primer sequences for RT-qPCR assays are shown in Table 1.
Table 1.
Gene | Forward primer | Reverse primer |
---|---|---|
UPKIb | AGCCTCTACCCGCTGCTTGA | GGAAGAGGTTGGGTGTGAAA |
UPKIIIa | TCGTTATCACGTCCATCCTG | CAGACGTGTATGAAGGCTCC |
GADPH | TGCACCACCAACTGCTTGGCA | GGCATGGACCGAGGTCATGAG |
Freeze-fracture replica immunolabelling (FRIL)
For the detection of the intramembrane distribution of UPs, the FRIL technique was performed as described previously24. UPs were immunolabelled with a rabbit polyclonal antibody against all four UPs (anti-UPs)1. After washing in PBS, goat anti-rabbit IgG coupled to 18-nm gold particles were applied (Jackson Immunoresearch, West Grove, NA, USA). Immunolabelled replicas were observed in a Philips 410 transmission electron microscope (FEI, Eindhoven, The Netherlands).
cDNA constructs of UPs
We generated four UP cDNA constructs. The UPIb and UPIIIa cDNA clones from DNASU Plasmid Repository were amplified by PCR using forward and reverse primers (see Supplementary Table S1). The PCR product was then ligated with a pcDNA3 vector (Clontech Laboratories, Inc., Takara Bio Europe AB, Göteborg, Sweden) or pEGFP-N1 (InvitrogenTM) using restriction sites inserted in the forward and reverse primers (Sigma‒Aldrich). All DNA constructs were sent to DNA sequencing (Primm, Italy). The glycosylphosphatidylinositol (GPI-GFP) construct was kindly provided by Prof. Jennifer Lippincott-Schwartz (NIH, Bethesda, MD).
Cell transfection
According to the manufacturer’s instructions, UCs, MDCK, and HeLa cells were transfected with NanoJuice (Merck, Darmstadt, Germany), Lipofectamin 2000 (Invitrogen) or Mirus (Mirus Bio LLC, Wisconsin, USA), respectively. The transfection was performed 24 h after plating the cells. Combinations of used constructs in different cell-types are presented in Supplementary Table S2. Transfection with GPI-GFP was performed as a control, which presented cells with increased non-relevant membrane protein. After transfection, the cells were washed with a cell-type specific medium and incubated overnight. When non-polarized MDCK or HeLa cells were used, the further experiments were performed 24 h after the transfection. When polarized UCs or MDCK cells were used, the further experiments were performed 5 days after the transfection.
Fluorescence labelling
The cells were fixed in 4% formaldehyde for 10 min at room temperature, washed in PBS and preincubated with blocking buffer (0.5% BSA, 0.1% saponin, and 50 mM ammonium chloride in PBS). Immunolabelling was done with the following mouse monoclonal antibodies: anti-ZO-1 (1:20; Zymed Laboratories, Thermo Fisher Scientific, Waltham, MA, USA), anti-giantin (1:1000; Enzo Life Sciences, Farmingdale, New Yourk, USA), anti-GM130 (1:500; BD Transduction Laboratories, BD Biosciences, New Jersey, USA), anti-α-tubulin (1:100; Sigma‒Aldrich) anti-golgin 97 (1:1000; BD Transduction Laboratories), anti-occludin (1:50; BD Transduction Laboratories), anti-COPI (1:800; BD Transduction Laboratories), anti-COPII (1:100; BD Transduction Laboratories), anti-clathrin (1:1000; Abcam, Cambridge, UK); and polyclonal rabbit antibodies: anti-UPIb (1:200), anti-UPIIIa (1:50) and anti-UPs (1:1000); all three were a gift from Prof. Tung-Tien Sun, New York University, School of Medicine), anti-GFP (1:250; Abcam), and anti-caspase 3 (1:1000; R&D Systems, Minneapolis, USA). After washing in PBS, goat anti-rabbit and goat anti-mouse IgG conjugated with Alexa Fluor 488 or Alexa Fluor 555 were applied (1:400; Molecular Probes®, InvitrogenTM, Life technologies, Thermo Fisher Scientific, Waltham, MA, USA).
For labelling of F-actin, the cells were fixed in 4% formaldehyde for 10 min. After fixation, cells were washed in PBS and labelled with TRITC-labelled phalloidin (1:5, Sigma‒Aldrich) for 30 min at room temperature in the dark.
For ER labelling the ER-TrackerTM Blue-White DPX (Life Technologies) was used according to the manufacturer’s instructions. Live transfected cells were stained with 1 µM ER-Tracker for 20 min at 37 °C. The staining solution was removed and the cells were washed with a cell-type specific medium and fixed in 4% formaldehyde for 10 min. After labeling the cells were washed in PBS, mounted with Mowiol (Sigma‒Aldrich) or with DAPI-Vectashield (Vector Laboratories, Cambridgeshire, UK) and then examined with an inverted confocal microscope Zeiss LSM710 (Carl Zeiss, Gottingen, Germany) or with a fluorescence microscope AxioImager.Z1 (Carl Zeiss MicroImaging GmbH) with an ApoTome attachment for optical sectioning and three-dimensional reconstruction.
Immunofluorescence labeling of cryo semi-thin sections
Two-month urothelial models of normal porcine UCs were fixed in 4% formaldehyde in 0.1 M phosphate buffer, rinsed in PBS/20 mM Glycine, gently scraped from the surface, embedded in 12% gelatin, infused with 2.3 M sucrose and frozen in liquid nitrogen. Sections (300 nm thick) were cut at −80 °C, washed with PBS/20 mM Glycine and blocked with 1% BSA. Single immunolabeling of uroplakins was performed with rabbit polyclonal antibodies against UPIa (1:500), UPIb (1:500), UPII (1:100) and mouse monoclonal antibody against UPIIIa (a gift from Prof. Tung-Tien Sun, New York University, School of Medicine). Appropriate IgGs-AlexaFluor488 were used as secondary antibodies (1:400). For double immunolabeling the following combinations of antibodies were used: (i) mouse anti-COPI (1:1500; ref.66) and rabbit anti-UPs (1:10000; a gift from Prof. Tung-Tien Sun, New York University, School of Medicine), (ii) mouse anti-COPI and rabbit anti-giantin (1:1000; provided by Prof. Antonella De Matteis, TIGEM, Napoli), (iii) mouse anti-clathrin (1:300; BD Transduction Laboratories) and anti-UPs, (iv) mouse anti-clathrin and anti-giantin. Goat anti-mouse IgG with AlexaFluor488 and goat anti-rabbit IgG with AlexaFluor555 (both 1:400, Thermo Fisher Scientific) were used as secondary antibodies.
Scanning electron microscopy
Two-month urothelial models of normal porcine UCs were fixed in 4% (w/v) formaldehyde and 2.5% (v/v) glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4 for 2 h 45 min at 4 °C. The samples were rinsed in 0.1 M cacodylate buffer and postfixed in 1% osmium tetroxide in the same buffer for 1 h at 4 °C. Specimens were critical-point dried, sputter-coated with gold, and examined at 15 kV with a Jeol JSM 840 A scanning EM.
Immunoelectron microscopy
The MDCK and HeLa cells transfected with UPIb-EGFP or UPIb/UPIIIa were fixed as described previously66,67. Cells were incubated with the anti-EGFP antibody (1:250; Abcam), washed in PBS and incubated in anti-rabbit Fab’ fragments coupled to 1.4-nm nanogold (1:100; Molecular Probes). Nanogold was enlarged by the GoldEnhance protocol (Nanoprobes Inc., Yaphank, NY, USA). Sections of 65-nm thickness were collected and EM images were acquired by a TechaiTM-G2 Spirit electron microscope equipped with a VELETTA CCD digital camera (FEI, Eindhoven, The Netherlands).
Quantitative analysis of GA structure
To determine the influence of the UP transport on GA structure, the MDCK and HeLa were first transfected with specific cDNA constructs (see Supplementary Tables S1 and S2) and then immunolabelled with anti-giantin and anti-UP antibodies. Ten random 3D images were taken with a confocal microscope Zeiss LSM710 (Carl Zeiss, Gottingen, Germany) and then the optical sections were analyzed (z-axis step set to 0.365 μm) as described previously26. Briefly, the number of GA fragments visible in Z-stacking panels of the GA in UP-expressing cells was counted with ParticleCO software (Celica, Ljubljana, Slovenia). With the custom software tool based on Matlab (Matworks, Natick, USA), we computed the average Euclidean distance between all pairs of GA fragments in each cell. Then we classified all fragments into clusters by creating a hierarchical cluster tree from Euclidean distances. The criterion for characterization was the inconsistency coefficient, which was set to a value of one. To find the variability in the number of clusters and in the number of fragments, the number of fragments per cluster was calculated for each cell. Data were analyzed using an analysis of variance (ANOVA). Differences with a p value < 0.05 were considered statistically significant.
The synchronization of protein release from GA with brefeldin A
To examine the dynamics of the UPIb/UPIIIa- EGFP-transport, the synchronization of protein release from GA was induced. Transfected MDCK cells were incubated overnight with 5 µg/ml brefeldin A (Sigma-Aldrich) that blocks movement of newly synthesized membrane proteins from the ER to the GA68. Cells were then washed with culture medium with 0.02 M Hepes and shifted from 37 °C to 20 °C for 2 h to allow accumulation of UPs in the GA. After this temperature block, cells were shifted to 37 °C to monitor UP release from the GA. Samples were either analyzed with time-lapse confocal microscopy or prepared for immunofluorescence and immunoelectron microscopy. Synchronization of protein release from the GA in UCs and HeLa cells was not achieved, since UCs did not survive the treatment with brefeldin A and HeLa cells were not responding to treatment.
Tannic acid treatment for prevention of the vesicle fusion with the PM
To study the correlation between the UPIb/UPIIIa-EGFP signals and COPI, COPII and clathrin signals, first the synchronization of protein release from GA was induced with brefeldin A. After synchronization of proteins, the MDCK cells were washed with culture medium with 0.02 M Hepes. Then the cells were shifted from 37 °C to 20 °C for 2 h to accumulate proteins in the GA. After this temperature block, cells were shifted to 32 °C for 45 min and treated with 0.5% tannic acid (Fluka, Sigma‒Aldrich) to prevent fusion of UPIb/UPIIIa-EGFP positive vesicles with the plasma membrane. Samples were then prepared for immunofluorescence microscopy using antibodies against COPI, COPII and clathrin proteins.
Quantification of co-localization
For the quantification of co-localization, the Pearson’s correlation coefficients were calculated from the raw optical sections for the pairing of UPIb/UPIIIa-EGFP and the other vesicle markers (COPI, COPII, clathrin). The Pearson’s correlation coefficients were then calculated using the JaCoP plugin (Image J) from three z-stack images. The Pearson’s coefficients were averaged, and a standard error of the mean was calculated. The degree of co- localization from the Pearson’s coefficients was categorized according to69: very strong (0.85 to 1.0), strong (0.49 to 0.84), moderate (0.1 to 0.48), weak (−0.26 to 0.09) and very weak (−1 to −0.27).
Nocodazole and cytochalasin D treatment
To study the influence of MTs and AFs on the UP transport we synchronized protein release from the GA in transfected MDCK cells by brefeldin A, as described above. During UP accumulation in the GA at 20 °C, the cells were treated with 66 μM nocodazole (NOC) for 15 min or 20 µg/ml cytochalasin D (CytD) for 30 min to disassemble MTs and AFs, respectively. The cells were then transferred to 37 °C to perform time lapse confocal microscopy.
Time lapse confocal microscopy
Dynamics of UP transport in nocodazole and cytochalasin D treated MDCK cells was analyzed by time lapse confocal microscopy. The details of the method are described in ref.70. Briefly, the time-lapse images of EGFP-labeled UPs in cells were acquired every 3.8 s with an inverted confocal microscope Zeiss LSM710 (Carl Zeiss, Gottingen, Germany) with a microscope stage incubator chamber that allows controlled conditions (37 °C, 95% humidity, 5% CO2). The EGFP was excited with the 488 nm line of a krypton-argon laser and an appropriate band filter was used. The time-lapse images were acquired with the ZEN Time Lapse module (Carl Zeiss, Gottingen, Germany) and analyzed by ParticleTR software (Celica, Ljubljana, Slovenia; http://celicabiomedical.com/Docs/ParticleTR.pdf). To avoid experimental error due to cell movement, only cells that did not move relative to the substratum during the acquisition were analyzed. The instantaneous rate of transport was determined by dividing the distance travelled by a vesicle with time, excluding the time when the vesicle halted or reversed its direction.
Electronic supplementary material
Acknowledgements
We thank Antonella De Matteis and Tung-Tien Sun for the generous gift of antibodies, Jennifer Lippincott-Schwartz for providing GPI-GFP construct and Maruša Debeljak for providing primers for RT-qPCR. We express gratitude to Sanja Čabraja, Linda Štrus, Nada Pavlica Dubarič, Sabina Železnik and Karin Schlattman for their technical assistance and Eva Lasič for English editing of the manuscript. This work was funded by the Slovenian Research Agency (Grant No. P3-0108, J3-7494) and AIRC (Grant No. IG-2015).
Author Contributions
M.E.K. and R.P. designed the study; T.V., G.C., S.I., E.P., N.R., and H.R. performed the experiments. T.V., H.R., M.K., R.R., R.P. and M.E.K. interpreted the results and prepared the manuscript.
Competing Interests
The authors declare that they have no competing interests.
Footnotes
Electronic supplementary material
Supplementary information accompanies this paper at 10.1038/s41598-017-13103-x.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Roman Polishchuk, Email: polish@tigem.it.
Mateja Erdani Kreft, Email: mateja.erdani@mf.uni-lj.si.
References
- 1.Wu XR, Manabe M, Yu J, Sun TT. Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation. J Biol Chem. 1990;265:19170–19179. [PubMed] [Google Scholar]
- 2.Wu XR, et al. Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins. The Journal of biological chemistry. 1994;269:13716–13724. [PubMed] [Google Scholar]
- 3.Liang FX, et al. Organization of uroplakin subunits: transmembrane topology, pair formation and plaque composition. The Biochemical journal. 2001;355:13–18. doi: 10.1042/bj3550013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Min G, Zhou G, Schapira M, Sun TT, Kong XP. Structural basis of urothelial permeability barrier function as revealed by Cryo-EM studies of the 16 nm uroplakin particle. Journal of cell science. 2003;116:4087–4094. doi: 10.1242/jcs.00811. [DOI] [PubMed] [Google Scholar]
- 5.Lobban ED, et al. Uroplakin gene expression by normal and neoplastic human urothelium. The American journal of pathology. 1998;153:1957–1967. doi: 10.1016/S0002-9440(10)65709-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Olsburgh J, et al. Uroplakin gene expression in normal human tissues and locally advanced bladder cancer. The Journal of pathology. 2003;199:41–49. doi: 10.1002/path.1252. [DOI] [PubMed] [Google Scholar]
- 7.Kachar B, et al. Three-dimensional analysis of the 16 nm urothelial plaque particle: luminal surface exposure, preferential head-to-head interaction, and hinge formation. J Mol Biol. 1999;285:595–608. doi: 10.1006/jmbi.1998.2304. [DOI] [PubMed] [Google Scholar]
- 8.Zupančič, D. et al. Molecular ultrastructure of the urothelial surface: Insights from a combination of various microscopic techniques. Microsc Res Tech, doi:10.1002/jemt.22412 (2014). [DOI] [PubMed]
- 9.Carpenter AR, et al. Uroplakin 1b is critical in urinary tract development and urothelial differentiation and homeostasis. Kidney Int. 2016;89:612–624. doi: 10.1016/j.kint.2015.11.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hu P, et al. Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux. The Journal of cell biology. 2000;151:961–972. doi: 10.1083/jcb.151.5.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Jiang S, et al. Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for disease heterogeneity. Kidney international. 2004;66:10–19. doi: 10.1111/j.1523-1755.2004.00703.x. [DOI] [PubMed] [Google Scholar]
- 12.Jenkins D, et al. Mutation analyses of Uroplakin II in children with renal tract malformations. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. 2006;21:3415–3421. doi: 10.1093/ndt/gfl465. [DOI] [PubMed] [Google Scholar]
- 13.Tu L, Sun TT, Kreibich G. Specific heterodimer formation is a prerequisite for uroplakins to exit from the endoplasmic reticulum. Molecular biology of the cell. 2002;13:4221–4230. doi: 10.1091/mbc.E02-04-0211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Xie B, et al. Distinct glycan structures of uroplakins Ia and Ib: structural basis for the selective binding of FimH adhesin to uroplakin Ia. The Journal of biological chemistry. 2006;281:14644–14653. doi: 10.1074/jbc.M600877200. [DOI] [PubMed] [Google Scholar]
- 15.Wu XR, Sun TT. Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein. Journal of cell science. 1993;106(Pt 1):31–43. doi: 10.1242/jcs.106.1.31. [DOI] [PubMed] [Google Scholar]
- 16.Malagolini N, Cavallone D, Wu XR, Serafini-Cessi F. Terminal glycosylation of bovine uroplakin III, one of the major integral-membrane glycoproteins of mammalian bladder. Biochimica et biophysica acta. 2000;1475:231–237. doi: 10.1016/S0304-4165(00)00073-8. [DOI] [PubMed] [Google Scholar]
- 17.Hu CC, et al. Assembly of a membrane receptor complex: roles of the uroplakin II prosequence in regulating uroplakin bacterial receptor oligomerization. The Biochemical journal. 2008;414:195–203. doi: 10.1042/BJ20080550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wu XR, Medina JJ, Sun TT. Selective interactions of UPIa and UPIb, two members of the transmembrane 4 superfamily, with distinct single transmembrane-domained proteins in differentiated urothelial cells. J Biol Chem. 1995;270:29752–29759. doi: 10.1074/jbc.270.50.29752. [DOI] [PubMed] [Google Scholar]
- 19.Hudoklin S, Jezernik K, Neumüller J, Pavelka M, Romih R. Electron tomography of fusiform vesicles and their organization in urothelial cells. PLoS One. 2012;7:e32935. doi: 10.1371/journal.pone.0032935. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Hudoklin S, Jezernik K, Neumüller J, Pavelka M, Romih R. Urothelial plaque formation in post-Golgi compartments. PLoS One. 2011;6:e23636. doi: 10.1371/journal.pone.0023636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Robertson JD. The structure of biological membranes. Current status. Arch Intern Med. 1972;129:202–228. doi: 10.1001/archinte.1972.00320020046004. [DOI] [PubMed] [Google Scholar]
- 22.Warren RC, Hicks RM. Structure of the subunits in the thick luminal membrane of rat urinary bladder. Nature. 1970;227:280–281. doi: 10.1038/227280b0. [DOI] [PubMed] [Google Scholar]
- 23.Hicks RM. The function of the golgi complex in transitional epithelium. Synthesis of the thick cell membrane. J Cell Biol. 1966;30:623–643. doi: 10.1083/jcb.30.3.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kreft ME, Robenek H. Freeze-fracture replica immunolabelling reveals urothelial plaques in cultured urothelial cells. PloS one. 2012;7:e38509. doi: 10.1371/journal.pone.0038509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hudoklin S, Zupancic D, Romih R. Maturation of the Golgi apparatus in urothelial cells. Cell Tissue Res. 2009;336:453–463. doi: 10.1007/s00441-009-0779-9. [DOI] [PubMed] [Google Scholar]
- 26.Kreft ME, et al. Golgi apparatus fragmentation as a mechanism responsible for uniform delivery of uroplakins to the apical plasma membrane of uroepithelial cells. Biol Cell. 2010;102:593–607. doi: 10.1042/BC20100024. [DOI] [PubMed] [Google Scholar]
- 27.Veranic P, Jezernik K. Trajectorial organisation of cytokeratins within the subapical region of umbrella cells. Cell motility and the cytoskeleton. 2002;53:317–325. doi: 10.1002/cm.10077. [DOI] [PubMed] [Google Scholar]
- 28.Kreft ME, Romih R, Sterle M. Antigenic and ultrastructural markers associated with urothelial cytodifferentiation in primary explant outgrowths of mouse bladder. Cell biology international. 2002;26:63–74. doi: 10.1006/cbir.2001.0829. [DOI] [PubMed] [Google Scholar]
- 29.Romih R, Veranic P, Jezernik K. Actin filaments during terminal differentiation of urothelial cells in the rat urinary bladder. Histochem Cell Biol. 1999;112:375–380. doi: 10.1007/s004180050419. [DOI] [PubMed] [Google Scholar]
- 30.Tratnjek, L., Romih, R. & Kreft, M. E. Differentiation-dependent rearrangements of actin filaments and microtubules hinder apical endocytosis in urothelial cells. Histochem Cell Biol, doi:10.1007/s00418-017-1566-4 (2017). [DOI] [PubMed]
- 31.Višnjar T, Kreft ME. Air-liquid and liquid-liquid interfaces influence the formation of the urothelial permeability barrier in vitro. In Vitro Cell Dev Biol Anim. 2013;49:196–204. doi: 10.1007/s11626-013-9585-5. [DOI] [PubMed] [Google Scholar]
- 32.Višnjar T, Kocbek P, Kreft ME. Hyperplasia as a mechanism for rapid resealing urothelial injuries and maintaining high transepithelial resistance. Histochem Cell Biol. 2012;137:177–186. doi: 10.1007/s00418-011-0893-0. [DOI] [PubMed] [Google Scholar]
- 33.Višnjar T, Kreft ME. The complete functional recovery of chitosan-treated biomimetic hyperplastic and normoplastic urothelial models. Histochem Cell Biol. 2015;143:95–107. doi: 10.1007/s00418-014-1265-3. [DOI] [PubMed] [Google Scholar]
- 34.Koss LG. The asymmetric unit membranes of the epithelium of the urinary bladder of the rat. An electron microscopic study of a mechanism of epithelial maturation and function. Lab Invest. 1969;21:154–168. [PubMed] [Google Scholar]
- 35.Zupančič D, Zakrajšek M, Zhou G, Romih R. Expression and localization of four uroplakins in urothelial preneoplastic lesions. Histochem Cell Biol. 2011;136:491–500. doi: 10.1007/s00418-011-0857-4. [DOI] [PubMed] [Google Scholar]
- 36.Garthwaite M, et al. Use of donor bladder tissues for in vitro research. BJU Int. 2014;113:160–166. doi: 10.1111/bju.12285. [DOI] [PubMed] [Google Scholar]
- 37.Hu CC, et al. Assembly of urothelial plaques: tetraspanin function in membrane protein trafficking. Mol Biol Cell. 2005;16:3937–3950. doi: 10.1091/mbc.E05-02-0136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Mukherjee S, Chiu R, Leung SM, Shields D. Fragmentation of the Golgi apparatus: an early apoptotic event independent of the cytoskeleton. Traffic. 2007;8:369–378. doi: 10.1111/j.1600-0854.2007.00542.x. [DOI] [PubMed] [Google Scholar]
- 39.Polishchuk EV, Di Pentima A, Luini A, Polishchuk RS. Mechanism of constitutive export from the golgi: bulk flow via the formation, protrusion, and en bloc cleavage of large trans-golgi network tubular domains. Mol Biol Cell. 2003;14:4470–4485. doi: 10.1091/mbc.E03-01-0033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Hirschberg K, et al. Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells. J Cell Biol. 1998;143:1485–1503. doi: 10.1083/jcb.143.6.1485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Negrete HO, Lavelle JP, Berg J, Lewis SA, Zeidel ML. Permeability properties of the intact mammalian bladder epithelium. The American journal of physiology. 1996;271:F886–894. doi: 10.1152/ajprenal.1996.271.4.F886. [DOI] [PubMed] [Google Scholar]
- 42.Kreft ME, Hudoklin S, Jezernik K, Romih R. Formation and maintenance of blood-urine barrier in urothelium. Protoplasma. 2010;246:3–14. doi: 10.1007/s00709-010-0112-1. [DOI] [PubMed] [Google Scholar]
- 43.Ellis MA, Potter BA, Cresawn KO, Weisz OA. Polarized biosynthetic traffic in renal epithelial cells: sorting, sorting, everywhere. Am J Physiol Renal Physiol. 2006;291:F707–713. doi: 10.1152/ajprenal.00161.2006. [DOI] [PubMed] [Google Scholar]
- 44.Fölsch H, Mattila PE, Weisz OA. Taking the scenic route: biosynthetic traffic to the plasma membrane in polarized epithelial cells. Traffic. 2009;10:972–981. doi: 10.1111/j.1600-0854.2009.00927.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Baldwin TA, Ostergaard HL. Developmentally regulated changes in glucosidase II association with, and carbohydrate content of, the protein tyrosine phosphatase CD45. J Immunol. 2001;167:3829–3835. doi: 10.4049/jimmunol.167.7.3829. [DOI] [PubMed] [Google Scholar]
- 46.Tian G, et al. An unconventional secretory pathway mediates the cilia targeting of peripherin/rds. J Neurosci. 2014;34:992–1006. doi: 10.1523/JNEUROSCI.3437-13.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Cleyrat C, et al. Mpl traffics to the cell surface through conventional and unconventional routes. Traffic. 2014;15:961–982. doi: 10.1111/tra.12185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Chiu R, Novikov L, Mukherjee S, Shields D. A caspase cleavage fragment of p115 induces fragmentation of the Golgi apparatus and apoptosis. J Cell Biol. 2002;159:637–648. doi: 10.1083/jcb.200208013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Rudick VL, Rudick MJ, Brun-Zinkernagel AM. Amplification of the Golgi complex in MDCK cells secreting human growth hormone. J Cell Sci. 1993;104(Pt 2):509–520. doi: 10.1242/jcs.104.2.509. [DOI] [PubMed] [Google Scholar]
- 50.Lu Z, Joseph D, Bugnard E, Zaal KJ, Ralston E. Golgi complex reorganization during muscle differentiation: visualization in living cells and mechanism. Mol Biol Cell. 2001;12:795–808. doi: 10.1091/mbc.12.4.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Mironov AA, Sesorova IS, Seliverstova EV, Beznoussenko GV. Different Golgi ultrastructure across species and tissues: Implications under functional and pathological conditions, and an attempt at classification. Tissue Cell. 2017;49:186–201. doi: 10.1016/j.tice.2016.12.002. [DOI] [PubMed] [Google Scholar]
- 52.Bergmann JE, Kupfer A, Singer SJ. Membrane insertion at the leading edge of motile fibroblasts. Proc Natl Acad Sci USA. 1983;80:1367–1371. doi: 10.1073/pnas.80.5.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Wakana Y, et al. A new class of carriers that transport selective cargo from the trans Golgi network to the cell surface. EMBO J. 2012;31:3976–3990. doi: 10.1038/emboj.2012.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Luini A, Ragnini-Wilson A, Polishchuck RS, De Matteis MA. Large pleiomorphic traffic intermediates in the secretory pathway. Curr Opin Cell Biol. 2005;17:353–361. doi: 10.1016/j.ceb.2005.06.012. [DOI] [PubMed] [Google Scholar]
- 55.Luini A, Mironov AA, Polishchuk EV, Polishchuk RS. Morphogenesis of post-Golgi transport carriers. Histochem Cell Biol. 2008;129:153–161. doi: 10.1007/s00418-007-0365-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Kreitzer G, Marmorstein A, Okamoto P, Vallee R, Rodriguez-Boulan E. Kinesin and dynamin are required for post-Golgi transport of a plasma-membrane protein. Nat Cell Biol. 2000;2:125–127. doi: 10.1038/35000081. [DOI] [PubMed] [Google Scholar]
- 57.Kreitzer G, et al. Three-dimensional analysis of post-Golgi carrier exocytosis in epithelial cells. Nat Cell Biol. 2003;5:126–136. doi: 10.1038/ncb917. [DOI] [PubMed] [Google Scholar]
- 58.Porat-Shliom N, Milberg O, Masedunskas A, Weigert R. Multiple roles for the actin cytoskeleton during regulated exocytosis. Cell Mol Life Sci. 2013;70:2099–2121. doi: 10.1007/s00018-012-1156-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Potokar M, Kreft M, Pangrsic T, Zorec R. Vesicle mobility studied in cultured astrocytes. Biochem Biophys Res Commun. 2005;329:678–683. doi: 10.1016/j.bbrc.2005.02.030. [DOI] [PubMed] [Google Scholar]
- 60.Potokar M, et al. Cytoskeleton and vesicle mobility in astrocytes. Traffic. 2007;8:12–20. doi: 10.1111/j.1600-0854.2006.00509.x. [DOI] [PubMed] [Google Scholar]
- 61.Tabb JS, Molyneaux BJ, Cohen DL, Kuznetsov SA, Langford GM. Transport of ER vesicles on actin filaments in neurons by myosin V. J Cell Sci. 1998;111(Pt 21):3221–3234. doi: 10.1242/jcs.111.21.3221. [DOI] [PubMed] [Google Scholar]
- 62.Kreft ME, Jezernik K, Kreft M, Romih R. Apical plasma membrane traffic in superficial cells of bladder urothelium. Annals of the New York Academy of Sciences. 2009;1152:18–29. doi: 10.1111/j.1749-6632.2008.04004.x. [DOI] [PubMed] [Google Scholar]
- 63.Corda D, Barretta ML, Cervigni RI, Colanzi A. Golgi complex fragmentation in G2/M transition: An organelle-based cell-cycle checkpoint. IUBMB Life. 2012;64:661–670. doi: 10.1002/iub.1054. [DOI] [PubMed] [Google Scholar]
- 64.Visnjar T, Kocbek P, Kreft ME. Hyperplasia as a mechanism for rapid resealing urothelial injuries and maintaining high transepithelial resistance. Histochem Cell Biol. 2012;137:177–186. doi: 10.1007/s00418-011-0893-0. [DOI] [PubMed] [Google Scholar]
- 65.Visnjar T, Kreft ME. Air-liquid and liquid-liquid interfaces influence the formation of the urothelial permeability barrier in vitro. In Vitro Cell Dev Biol Anim. 2013;49:196–204. doi: 10.1007/s11626-013-9585-5. [DOI] [PubMed] [Google Scholar]
- 66.Palmer DJ, Helms JB, Beckers CJ, Orci L, Rothman JE. Binding of coatomer to Golgi membranes requires ADP-ribosylation factor. J Biol Chem. 1993;268:12083–12089. [PubMed] [Google Scholar]
- 67.Polishchuk, R. S. & Mironov, A. A. Correlative video light/electron microscopy. Curr Protoc Cell Biol Chapter 4, Unit4.8, doi:10.1002/0471143030.cb0408s11 (2001). [DOI] [PubMed]
- 68.Lippincott-Schwartz J, Yuan LC, Bonifacino JS, Klausner RD. Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell. 1989;56:801–813. doi: 10.1016/0092-8674(89)90685-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Zinchuk V, Wu Y, Grossenbacher-Zinchuk O. Bridging the gap between qualitative and quantitative colocalization results in fluorescence microscopy studies. Sci Rep. 2013;3:1365. doi: 10.1038/srep01365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Polishchuk RS, Polishchuk EV, Mironov AA. Coalescence of Golgi fragments in microtubule-deprived living cells. Eur J Cell Biol. 1999;78:170–185. doi: 10.1016/S0171-9335(99)80096-X. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.